Completed PHASE4 INTERVENTIONAL 16-arm NCT02117401

A Prospective, Multi-center, Randomized Controlled Study of Muscle Relaxation Effect and Safety of Mivacurium Chloride in Pediatric Surgery Patients

A Prospective, Multi-center, Randomized Controlled Study of Neuromuscular Blocking Effect and Safety of Mivacurium Chloride in Pediatric Patients

Sponsor: Jiangsu Nhwa Pharmaceutical Co., Ltd.

Conditions Efficacy and Safety of Mivacurium Chloride for Pediatric Patients

Interventions Remifentanil ketamine midazolam mivacurium chloride propofol

Updated 5 times since 2017 Last updated: Jul 14, 2014 Started: Jan 31, 2012 Primary completion: Jun 30, 2013 Completion: Jun 30, 2013

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE4 clinical study on Efficacy and Safety of Mivacurium Chloride for Pediatric Patients, this trial is completed. The trial is conducted by Jiangsu Nhwa Pharmaceutical Co., Ltd. and has accumulated 5 data snapshots since 2012. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Jun 2018 — Jan 2021 [monthly]

Completed PHASE4
Jan 2017 — Jun 2018 [monthly]

Completed PHASE4

First recorded

Jan 2012

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Jiangsu Nhwa Pharmaceutical Co., Ltd.

Data source: Jiangsu Nhwa Pharmaceutical Co., Ltd.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.